精選本院14項優質技術，參加2019北美生物科技產業展。
- MAP4K3 is a therapeutic target for cancer and IL-17A-mediated autoimmune disease
- Targeted antigen delivery system
- An Anti-Obesity Nanotechnology to Modulate Oil Absorption
- Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine
- A Novel Small Molecule Drug Conjugate (SMDC) with Positive Feedback Encoded Ability on Tumor Site Apoptosis
- Genome Data Bank and Cancer Precision Medicine of Hepatocarcinoma (HCC) and Upper Tract Urothelial Carcinoma (UTUC)
- BPR6K471: A Novel Aurora Kinase Inhibitor Targeting SCLC with MYC Amplification
- DBPR807: A CXCR4-Targeted Antagonist
- DBPR215: Development of Stem Cell Mobilizers in Cell-Based Therapy
- DBPR211: A Peripheral CB1 Antagonist An IND Approved First-in-Class Drug Candidate for T2DM
- DBPR117: A Precision Medicine (mAb) Targeting RSPO3/Wnt-Mediated Tumorigenesis
- DBPR114: an IND Approved Multi-targeted Kinase Inhibitor for Anticancer
- A novel antibody against Aβ possessing diagnostic and therapeutic potentials for Alzheimer’s disease
- AI-based mosquito trap